EMBLAVEO INJECTION

About EMBLAVEO INJECTION

Emblaveo Injection is a combination of Meropenem and Vaborbactam, used for the treatment of serious and life-threatening bacterial infections caused by multidrug-resistant Gram-negative organisms. It is especially effective against carbapenem-resistant Enterobacteriaceae (CRE). This injectable antibiotic is commonly used in hospital and critical care settings under strict medical supervision.

Composition:

• Meropenem

• Vaborbactam

Indications / Uses:

• Complicated urinary tract infections (cUTI)

• Hospital-acquired bacterial infections

• Ventilator-associated pneumonia (as prescribed)

• Severe infections caused by resistant Gram-negative bacteria

Key Benefits:

• Advanced beta-lactam/beta-lactamase inhibitor combination

• Effective against resistant bacterial strains

• Trusted option in ICU and tertiary care hospitals

• High clinical efficacy and safety profile

Dosage & Administration:
Dosage should be determined by a qualified healthcare professional based on the patients condition, age, and severity of infection. Administered intravenously.

Storage Instructions:

• Store below 25C

• Protect from light

• Keep out of reach of children

Packaging Type:

• Injection / Vial